3ZPR
Thermostabilised turkey beta1 adrenergic receptor with 4-methyl-2-(piperazin-1-yl) quinoline bound
Summary for 3ZPR
Entry DOI | 10.2210/pdb3zpr/pdb |
Related | 3ZPQ |
Descriptor | BETA-1 ADRENERGIC RECEPTOR, SODIUM ION, CHOLESTEROL HEMISUCCINATE, ... (6 entities in total) |
Functional Keywords | membrane protein, gpcr, fragment screening, aryl piperazine, structure based drug design |
Biological source | MELEAGRIS GALLOPAVO (TURKEY) |
Total number of polymer chains | 2 |
Total formula weight | 77410.94 |
Authors | Christopher, J.A.,Congreve, M.,Dore, A.S.,Marshall, F.H.,Myszka, D.G.,Brown, J.,Koglin, M.,Tehan, B.,Errey, J.C.,Tate, C.G.,Warne, T. (deposition date: 2013-03-01, release date: 2013-04-03, Last modification date: 2024-10-23) |
Primary citation | Christopher, J.,Brown, J.,Dore, A.,Errey, J.,Koglin, M.,Marshall, F.H.,Myszka, D.,Rich, R.L.,Tate, C.G.,Tehan, B.,Warne, T.,Congreve, M. Biophysical Fragment Screening of the Beta1-Adrenergic Receptor: Identification of High Affinity Aryl Piperazine Leads Using Structure-Based Drug Design. J.Med.Chem., 56:3446-, 2013 Cited by PubMed Abstract: Biophysical fragment screening of a thermostabilized β1-adrenergic receptor (β1AR) using surface plasmon resonance (SPR) enabled the identification of moderate affinity, high ligand efficiency (LE) arylpiperazine hits 7 and 8. Subsequent hit to lead follow-up confirmed the activity of the chemotype, and a structure-based design approach using protein-ligand crystal structures of the β1AR resulted in the identification of several fragments that bound with higher affinity, including indole 19 and quinoline 20. In the first example of GPCR crystallography with ligands derived from fragment screening, structures of the stabilized β1AR complexed with 19 and 20 were determined at resolutions of 2.8 and 2.7 Å, respectively. PubMed: 23517028DOI: 10.1021/JM400140Q PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.7 Å) |
Structure validation
Download full validation report